Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India
--------------------------------------------------------------------
Source: CNBC
Published: 2026-04-10 15:54 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Natural Disasters, Economy & Finance, Financial Markets, India, Drugs, Business & Economy, Environment & Climate, Asia Pacific
--------------------------------------------------------------------
Snippet:
The market share of India's most popular weight‑loss drugmaker, Eli Lilly, slipped in March, while rival Novo Nordisk held steady even as Indian generic drugmakers flooded the market with lower‑priced copies.
--------------------------------------------------------------------